Thomas Bernhardt
Overview
Explore the profile of Thomas Bernhardt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu X, Li J, Chua W, Pages M, Shi J, Hermoso J, et al.
Proc Natl Acad Sci U S A
. 2023 May;
120(21):e2301897120.
PMID: 37186861
The peptidoglycan (PG) cell wall produced by the bacterial division machinery is initially shared between the daughters and must be split to promote cell separation and complete division. In gram-negative...
2.
Akizawa T, Macdougall I, Berns J, Yamamoto H, Taguchi M, Iekushi K, et al.
Nephron
. 2019 Aug;
143(4):243-254.
PMID: 31387097
Background/aims: The current treatment for anemia associated with chronic kidney disease (CKD) includes the administration of erythropoiesis stimulating agents (ESAs) combined with iron supplementation. Molidustat, a hypoxia-inducible factor prolyl hydroxylase...
3.
Akizawa T, Macdougall I, Berns J, Bernhardt T, Staedtler G, Taguchi M, et al.
Am J Nephrol
. 2019 Mar;
49(4):271-280.
PMID: 30852574
Background: Molidustat, a novel hypoxia-inducible factor-prolyl hydroxylase inhibitor, is being investigated for the treatment of anemia associated with chronic kidney disease (CKD). The efficacy and safety of molidustat were recently...
4.
Macdougall I, Akizawa T, Berns J, Bernhardt T, Krueger T
Clin J Am Soc Nephrol
. 2018 Dec;
14(1):28-39.
PMID: 30559105
Background And Objectives: The efficacy and safety of molidustat, a hypoxia-inducible factor-prolyl hydroxylase inhibitor, have been evaluated in three 16-week, phase 2b studies in patients with CKD and anemia who...
5.
Lupoli T, Lebar M, Markovski M, Bernhardt T, Kahne D, Walker S
J Am Chem Soc
. 2013 Dec;
136(1):52-5.
PMID: 24341982
In Escherichia coli , the bifunctional penicillin-binding proteins (PBPs), PBP1A and PBP1B, play critical roles in the final stage of peptidoglycan (PG) biosynthesis. These synthetic enzymes each possess a PG...
6.
Gebert C, Brinkschmidt C, Bielack S, Bernhardt T, Jurgens H, Bocker W, et al.
Int J Surg Pathol
. 2006 Sep;
14(3):187-92.
PMID: 16959697
Matrix-producing bone lesions consist of a wide variety of benign and malignant conditions. With respect to morphology, an overlap exists between benign and malignant bone tumors that causes difficulties in...